Watch SCNI. Know when insiders buy.
One email the day a filing lands. Free.
SCNI
Scinai Immunotherapeutics Ltd.
1.48
−0.07 −4.84%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $20.5BP/E —DIV YIELD —FCF YIELD -0.03%REV TTM $1.3M +99.2%NET INCOME −$8.3M −273.2%NET CASH —52W 1.48 – 16.30SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2023 · Mar 31 | — | — | — | −$3.2M | −$3.5M | — | -0.00 | −$3.1M | $6K | −$3.1M | May 15 |
| Q1 2022 · Mar 31 | — | — | — | −$2.6M | −$2.5M | — | -0.00 | −$1.1M | $521K | −$1.6M | May 15 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.3M | -202.3% | −$7.5M | −$8.3M | -633.6% | — | −$6M | $24K | −$6.1M | — | — |
| FY2024 · to Dec 31 | $658K | -88.1% | −$8.6M | $4.8M | 728.9% | — | −$6.3M | $12K | −$6.3M | — | — |
| FY2023 · to Dec 31 | — | — | −$9.7M | −$6.5M | — | 0.00 | −$9.4M | $637K | −$10M | — | — |
| FY2022 · to Dec 31 | — | — | −$11.1M | −$5.8M | — | 0.01 | −$7.3M | $836K | −$8.1M | — | — |
| FY2021 · to Dec 31 | — | — | −$10.9M | −$8.2M | — | -0.02 | −$7.4M | $139K | −$7.6M | — | — |
Every number comes from Scinai Immunotherapeutics Ltd.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.